New Therapeutic Targets & A Rich Year For Approvals: EMA’s PRIME In 2020
Executive Summary
Last year saw the number of applications accepted onto the European Medicines Agency’s priority medicines scheme inch up and the notoriously high rejection rate for applications drop.